218 related articles for article (PubMed ID: 34326464)
1. PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Thura M; Ye Z; Al-Aidaroos AQ; Xiong Q; Ong JY; Gupta A; Li J; Guo K; Ang KH; Zeng Q
Commun Biol; 2021 Jul; 4(1):923. PubMed ID: 34326464
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
Niu N; Mercado-Uribe I; Liu J
Oncogene; 2017 Aug; 36(34):4887-4900. PubMed ID: 28436947
[TBL] [Abstract][Full Text] [Related]
3. PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
Thura M; Al-Aidaroos AQO; Yong WP; Kono K; Gupta A; Lin YB; Mimura K; Thiery JP; Goh BC; Tan P; Soo R; Hong CW; Wang L; Lin SJ; Chen E; Rha SY; Chung HC; Li J; Nandi S; Yuen HF; Zhang SD; Guan YK; So J; Zeng Q
JCI Insight; 2016 Jun; 1(9):e87607. PubMed ID: 27699276
[TBL] [Abstract][Full Text] [Related]
4. A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Chee CE; Ooi M; Lee SC; Sundar R; Heong V; Yong WP; Ng CH; Wong A; Lim JSJ; Tan DSP; Soo R; Tan JTC; Yang S; Thura M; Al-Aidaroos AQ; Chng WJ; Zeng Q; Goh BC
Target Oncol; 2023 May; 18(3):391-402. PubMed ID: 37060431
[TBL] [Abstract][Full Text] [Related]
5. PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
Thura M; Al-Aidaroos AQ; Gupta A; Chee CE; Lee SC; Hui KM; Li J; Guan YK; Yong WP; So J; Chng WJ; Ng CH; Zhou J; Wang LZ; Yuen JSP; Ho HSS; Yi SM; Chiong E; Choo SP; Ngeow J; Ng MCH; Chua C; Yeo ESA; Tan IBH; Sng JXE; Tan NYZ; Thiery JP; Goh BC; Zeng Q
Nat Commun; 2019 Jun; 10(1):2484. PubMed ID: 31171773
[TBL] [Abstract][Full Text] [Related]
6. Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs).
Bowers RR; Andrade MF; Jones CM; White-Gilbertson S; Voelkel-Johnson C; Delaney JR
BMC Cancer; 2022 Apr; 22(1):410. PubMed ID: 35421971
[TBL] [Abstract][Full Text] [Related]
7. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.
Zhang S; Mercado-Uribe I; Xing Z; Sun B; Kuang J; Liu J
Oncogene; 2014 Jan; 33(1):116-28. PubMed ID: 23524583
[TBL] [Abstract][Full Text] [Related]
8. Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.
Loh AHP; Thura M; Gupta A; Tan SH; Kuan KKY; Ang KH; Merchant K; Chang KTE; Yon HY; Chen Y; Cheng MHW; Mahadev A; Ng MCH; Seng MS; Iyer P; Chia PL; Soh SY; Zeng Q
Mol Ther Oncolytics; 2023 Sep; 30():153-166. PubMed ID: 37674627
[TBL] [Abstract][Full Text] [Related]
9. Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis.
Jiao Y; Yu Y; Zheng M; Yan M; Wang J; Zhang Y; Zhang S
Clin Transl Med; 2024 Feb; 14(2):e1567. PubMed ID: 38362620
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid targets chemo-resistant polyploid giant cancer cells.
Adibi R; Moein S; Gheisari Y
Sci Rep; 2023 Jan; 13(1):419. PubMed ID: 36624105
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Thura M; Ye Z; Al-Aidaroos AQ; Xiong Q; Ong JY; Gupta A; Li J; Guo K; Ang KH; Zeng Q
Commun Biol; 2021 Nov; 4(1):1282. PubMed ID: 34750497
[No Abstract] [Full Text] [Related]
12. Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.
Saini G; Joshi S; Garlapati C; Li H; Kong J; Krishnamurthy J; Reid MD; Aneja R
Semin Cancer Biol; 2022 Jun; 81():220-231. PubMed ID: 33766651
[TBL] [Abstract][Full Text] [Related]
13. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
14. Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer.
Chen J; Niu N; Zhang J; Qi L; Shen W; Donkena KV; Feng Z; Liu J
Curr Cancer Drug Targets; 2019; 19(5):360-367. PubMed ID: 29968537
[TBL] [Abstract][Full Text] [Related]
15. CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.
Lopez-Sánchez LM; Jimenez C; Valverde A; Hernandez V; Peñarando J; Martinez A; Lopez-Pedrera C; Muñoz-Castañeda JR; De la Haba-Rodríguez JR; Aranda E; Rodriguez-Ariza A
PLoS One; 2014; 9(6):e99143. PubMed ID: 24932611
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells.
Fan L; Zheng M; Zhou X; Yu Y; Ning Y; Fu W; Xu J; Zhang S
J Transl Med; 2023 Oct; 21(1):719. PubMed ID: 37833712
[TBL] [Abstract][Full Text] [Related]
17. High Migration and Invasion Ability of PGCCs and Their Daughter Cells Associated With the Nuclear Localization of S100A10 Modified by SUMOylation.
Zhao Q; Zhang K; Li Z; Zhang H; Fu F; Fu J; Zheng M; Zhang S
Front Cell Dev Biol; 2021; 9():696871. PubMed ID: 34336846
[TBL] [Abstract][Full Text] [Related]
18. Syncytin 1, CD9, and CD47 regulating cell fusion to form PGCCs associated with cAMP/PKA and JNK signaling pathway.
Fei F; Li C; Wang X; Du J; Liu K; Li B; Yao P; Li Y; Zhang S
Cancer Med; 2019 Jun; 8(6):3047-3058. PubMed ID: 31025548
[TBL] [Abstract][Full Text] [Related]
19. Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells.
Mukherjee S; Ali AM; Murty VV; Raza A
Med Oncol; 2022 Apr; 39(5):65. PubMed ID: 35478057
[TBL] [Abstract][Full Text] [Related]
20. Polyploid giant cancer cells and cancer progression.
Zhou X; Zhou M; Zheng M; Tian S; Yang X; Ning Y; Li Y; Zhang S
Front Cell Dev Biol; 2022; 10():1017588. PubMed ID: 36274852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
